Consistent with the model, where disruption of EphB6 signaling rescues T-ALL cells by protecting Akt activation, co-administration of doxorubicin and Akt inhibitor, perifosine, synergistically enhanced elimination of ΔB6-Jurkat cells (Fig. 4D). Here, AKT1 is linked to acute lymphoblastic leukemia.